AzTrials
AzTrials

Hip OsteoarthritisNCT06538519

Gait Analysis and Clinical Outcomes of Anterior and Lateral Approach Total Hip Arthroplasty.

A study testing total hip replacement using lateral approach, total hip replacement using anterior approach and gait analysis at 6wks, 3 months and 18 months in people with Hip Osteoarthritis, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this Prospective Randomized Study is to confirm presence or absence of differences in gait mechanics in direct anterior and lateral approaches for total hip arthroplasty. and to compare the clinical outcomes of both approaches. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Hip Osteoarthritis
What is being tested?
total hip replacement using lateral approach, total hip replacement using anterior approach and gait analysis at 6wks, 3 months and 18 months
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteEgypt
Study dates
3 Jan 2021to 10 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with primary osteoarthritis or osteonecrosis of the hip who consented for treatment with a total hip arthroplasty (THA) through an anterior or lateral approach.
  • Age between 20 - 60 years of age.
  • The participant had to be independent and physically active, which characterized as having the capacity to carry out daily tasks, ascend two flights of stairs, and able to walk for 15 minutes.

Who cannot join

  • Patients with bilateral hip affection.
  • Body mass index (BMI) greater than 40.
  • Diagnosis other than primary osteoarthritis or osteonecrosis.
  • Prior hip or spine surgery.
  • chronic uncontrolled comorbidities, psychological disorders.
  • American Society of Anaesthesiologists score (ASA) higher than 2
Show all 9Show fewer
  • chronic neurological deficits that influence gait.
  • any limb length discrepancy more than 1 cm.
  • Any postoperative complication that will lead to delay in weight bearing.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams University Hospitals

    Cairo, Abbasia

Other trials in Egypt

About this study

Official title: Gait Analysis and Clinical Outcomes of Anterior and Lateral Approach Total Hip Arthroplasty. A Prospective Randomized Study.

The goal of this Prospective Randomized Study is to confirm presence or absence of differences in gait mechanics in direct anterior and lateral approaches for total hip arthroplasty. and to compare the clinical outcomes of both approaches.

The main questions it aims to answer are:

if the anterior approach to the hip is faster recovery than lateral approach? if the anterior approach to the hip has better gait mechanics than lateral approach?

Participants will:

undergo one of the two approaches for total hip arthroplasty. All patients will be followed up at 2 weeks, 6 weeks, 3 months and 18 months. gait analysis will be done at 6wks, 3m, and 18months.

Being tested
total hip replacement using lateral approach, total hip replacement using anterior approach, gait analysis at 6wks, 3 months and 18 months
Keywords
arthroplasty
Medical subject headings
Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • total hip replacement using lateral approachProcedure or surgery

    In the lateral approach partial detachment of the anterior one-third of the gluteus medius muscle.

  • total hip replacement using anterior approachProcedure or surgery

    the anterior approach using an internervous plane between the tensor fascia latae and the sartorius muscle.

  • gait analysis at 6wks, 3 months and 18 monthsDevice

    gait analysis done in the gait lab at the mentioned postoperative periods

Study groups in NCT06538519
Study groupRoleWhat they receive
direct anterior approach groupActive comparatorNot described
Receives: Procedure: total hip replacement using anterior approach; Device: gait analysis at 6wks, 3 months and 18 months
lateral approach groupActive comparatorNot described
Receives: Procedure: total hip replacement using lateral approach; Device: gait analysis at 6wks, 3 months and 18 months

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. surgery time

    by ''Minute'' as the unit, no special description.

    Measured: intraoperative time starting from skin incision to skin closure

  2. hemoglobin drop

    hemoglobin drop level between pre and postoperative.

    Measured: postoperative day one

  3. hospital stays

    by ''Day'' as the unit, no special description. postoperative stay days from operation day to discharge day.

    Measured: immediately after the procedure

  4. pain score

    using visual analogue scale (VAS) from 0-10 the more scale the worst the pain

    Measured: 2 weeks 6 weeks 3 months 18 months

  5. Harris hip score

    for measuring hip function from 0-100 the more the score the better hip function

    Measured: 2 weeks 6 weeks 3 months 18 months

Secondary outcomes (1)
  1. gait analysis

    A single experienced physical medicine specialist will perform the gait analysis in a gait lab. Three-dimensional kinematic and kinetic data will be collected using eight high-speed infrared cameras (Quality motion analysis system, oqus 1 cameras), which can capture 240 frames per second, two force plates (Advanced Mechanical Technology Incorporated, AMTI), and 26 ten-millimeter passive retroreflective markers fixed on the subject using a double-face tape in specific landmarks on the subject in accordance to the modified institute Orthopedic Rizzoli (IOR ) model for full body marker set.

    Measured: at 6 weeks, 3 months, 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2024
  2. Study start3 Jan 2021
  3. Primary completion1 Jun 2023
  4. Study completion10 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06538519
Sponsor's protocol ID
MD 03/2021
Status last verified
Jul 2024
First submitted
7 Jul 2024
Last updated
5 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Wang Z, Bao HW, Hou JZ. Direct anterior versus lateral approaches for clinical outcomes after total hip arthroplasty: a meta-analysis. J Orthop Surg Res. 2019 Feb 26;14(1):63. doi: 10.1186/s13018-019-1095-z.

    PubMed 30808382
  • Pospischill M, Kranzl A, Attwenger B, Knahr K. Minimally invasive compared with traditional transgluteal approach for total hip arthroplasty: a comparative gait analysis. J Bone Joint Surg Am. 2010 Feb;92(2):328-37. doi: 10.2106/JBJS.H.01086.

    PubMed 20124059
  • Yue C, Kang P, Pei F. Comparison of Direct Anterior and Lateral Approaches in Total Hip Arthroplasty: A Systematic Review and Meta-Analysis (PRISMA). Medicine (Baltimore). 2015 Dec;94(50):e2126. doi: 10.1097/MD.0000000000002126.

    PubMed 26683920
  • Graves SC, Dropkin BM, Keeney BJ, Lurie JD, Tomek IM. Does Surgical Approach Affect Patient-reported Function After Primary THA? Clin Orthop Relat Res. 2016 Apr;474(4):971-81. doi: 10.1007/s11999-015-4639-5. Epub 2015 Nov 30.

    PubMed 26620966
  • Alecci V, Valente M, Crucil M, Minerva M, Pellegrino CM, Sabbadini DD. Comparison of primary total hip replacements performed with a direct anterior approach versus the standard lateral approach: perioperative findings. J Orthop Traumatol. 2011 Sep;12(3):123-9. doi: 10.1007/s10195-011-0144-0. Epub 2011 Jul 12.

    PubMed 21748384
  • Reichert JC, Volkmann MR, Koppmair M, Rackwitz L, Ludemann M, Rudert M, Noth U. Comparative retrospective study of the direct anterior and transgluteal approaches for primary total hip arthroplasty. Int Orthop. 2015 Dec;39(12):2309-13. doi: 10.1007/s00264-015-2732-8. Epub 2015 Mar 21.

    PubMed 25795247
  • Ilchmann T, Gersbach S, Zwicky L, Clauss M. Standard Transgluteal versus Minimal Invasive Anterior Approach in hip Arthroplasty: A Prospective, Consecutive Cohort Study. Orthop Rev (Pavia). 2013 Nov 6;5(4):e31. doi: 10.4081/or.2013.e31. eCollection 2013.

    PubMed 24416475
  • Yoo JI, Cha YH, Kim KJ, Kim HY, Choy WS, Hwang SC. Gait analysis after total hip arthroplasty using direct anterior approach versus anterolateral approach: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2019 Feb 8;20(1):63. doi: 10.1186/s12891-019-2450-2.

    PubMed 30736783

Questions about this trial

What is this clinical trial studying?

A study testing total hip replacement using lateral approach, total hip replacement using anterior approach and gait analysis at 6wks, 3 months and 18 months in people with Hip Osteoarthritis, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

surgery time (time frame: intraoperative time starting from skin incision to skin closure). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06538519, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in